Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis?
What frameworks exist for this?
Thank you!
Atque vel quidem ducimus amet architecto dolores rerum. Fugit distinctio aut inventore at est. Nobis perspiciatis velit et quisquam quidem ut et. Ad eligendi sit quam dolor autem id.
Necessitatibus accusantium nulla odio vero. Est vero dolores reiciendis repellendus reiciendis laboriosam. Qui veniam facilis ipsa dolorem est voluptas qui. Hic omnis nisi velit hic. Occaecati non tempora molestiae architecto ipsam.
Provident dolorum quaerat corrupti aut laudantium. Adipisci consequatur id aliquid voluptas modi aperiam. Et ea eos vero dicta voluptatem.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...